The combined use of sodium-glucose transport protein 2 (SGLT2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists may offer notable benefits for optimizing cardiovascular and renal outcomes...
The U.S. Food and Drug Administration approved Ozempic for the use of type 2 diabetes in 2017. Image: NurPhoto / Contributor (Getty Images) Novo Nordisk’s blockbuster...
In another ripple effect on the economy, Ozempic and other weight loss drugs are boosting sales of smaller-sized clothes. Apple AirPods and Watches could soon see...